Publications by authors named "Martyn Pt Kennedy"
Article Synopsis
- Incorporating spirometry into low-dose CT lung cancer screenings can help identify individuals with undiagnosed chronic obstructive pulmonary disease (COPD), although the effects of this approach are not fully understood.
- A study involving 2,391 participants found that 8.4% met criteria for referral to a respiratory team, with a significant number receiving new COPD diagnoses and treatments after further assessment.
- The research underscores the need for accurate postbronchodilator spirometry tests to confirm airflow obstruction before diagnosing and treating COPD, while also revealing challenges in using these screening results effectively.
Background: Chest X-ray (CXR) is the first-line investigation for lung cancer in many healthcare systems. An understanding of the consequences of false-negative CXRs on time to diagnosis, stage, and survival is limited.
Aim: To determine the sensitivity of CXR for lung cancer and to compare stage at diagnosis, time to diagnosis, and survival between those with CXR that detected, or did not detect, lung cancer.
Background: Chest X-ray (CXR) is the first-line investigation for lung cancer in many countries but previous research has suggested that the disease is not detected by CXR in approximately 20% of patients. The risk of lung cancer, with particular symptoms, following a negative CXR is not known.
Aim: To establish the sensitivity and specificity of CXR requested by patients who are symptomatic; determine the positive predictive values (PPVs) of each presenting symptom of lung cancer following a negative CXR; and determine whether symptoms associated with lung cancer are different in those who had a positive CXR result compared with those who had a negative CXR result.